Lobbying

Briotech's latest lobbying report covers Q2 2026, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Medical/Disease Research/Clinical Labs and Health Issues.

Briotech

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Briotech lobbying by quarter
Briotech lobbying by quarter
QuarterAmountReports
Q4 2022$45K1
Q1 2023$22.5K1
Q2 2023$7,5001
Q3 2023$7,5001
Q4 2023$7,5001
Q1 2024$7,5001
Q2 2024$7,5001
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$01
Q4 2025$01
Q1 2026$01
Q2 2026$01
Q3 2026$00

By issue

  • Medical research and clinical labs$60K · 14 reports
  • Health issues$22.5K · 1 reports
  • Trade$22.5K · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES15 reports
  • SENATE15 reports
  • Environmental Protection Agency (EPA)14 reports
  • Food & Drug Administration (FDA)14 reports
  • State, Dept of (DOS)1 reports

Firms it paid

Firm
Atlas Advocacy$105K15 quarters

Former officials lobbying for it

Former position
MATT SMITHSen Dan Coates/ EOP/ Dept. of VAQ2 2026
JON ROBINSON WADSWORTHNAQ4 2022

Lobbying reports

Filed by
08/12for Q2Atlas AdvocacyUnder $5,000
05/22for Q1Atlas AdvocacyUnder $5,000
02/09for Q4 2025Atlas AdvocacyUnder $5,000
25/11/12for Q3 2025Atlas AdvocacyUnder $5,000
25/08/11for Q2 2025Atlas AdvocacyUnder $5,000
25/05/09for Q1 2025Atlas AdvocacyUnder $5,000
25/02/04for Q4 2024Atlas AdvocacyUnder $5,000
24/11/06for Q3 2024Atlas AdvocacyUnder $5,000
24/08/20for Q2 2024Atlas Advocacy$7,500
24/05/15for Q1 2024Atlas Advocacy$7,500
24/02/05for Q4 2023Atlas Advocacy$7,500
23/11/10for Q3 2023Atlas Advocacy$7,500
23/08/28for Q2 2023Atlas Advocacy$7,500
23/07/28for Q4 2022Atlas Advocacy$45K
23/04/28for Q1 2023Atlas Advocacy$22.5K